Commercial insurance enrollees pay less for ultra-expensive drugs than Medicare Part D members: Study

(By Rylee Wilson for Becker’s Hospital Review)

Medicare Part D beneficiaries that don’t receive low-income subsidies spend 2.5 times more out-of-pocket on “ultra-expensive” drugs than those with commercial insurance, a study published May 26 in JAMA Health Forum found. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org